(Q67919655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

19 September 2019

main subject

phase I clinical trial

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

author name string

J. Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

N. Anderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

M. Bern

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

F. Coco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

T. Zipoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

C. Moore

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

L. Gonsalves

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1855174

10 December 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

15 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1855174

full work available at URL

10 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

744-746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer

19 September 2019

cites work

1

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Sequential methotrexate and 5-fluorouracil in the primary treatment of metastatic colorectal carcinoma

10 December 2022

2

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate

10 December 2022

3

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

Cancer Treatment Reports

4

65

747

Bedikian

1981

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers

10 December 2022

5

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

10 December 2022

6

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

10 December 2022

7

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

10 December 2022

8

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

10 December 2022

9

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

10 December 2022

10

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation

10 December 2022

12

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

Cancer Treatment Reports

14

68

1383

Kao

1984

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

10 December 2022

16

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer

10 December 2022

17

1 reference

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19910815)68:4%3C744::AID-CNCR2820680414%3E3.0.CO;2-R

10 December 2022

Identifiers

10.1002/1097-0142(19910815)68:4<744::AID-CNCR2820680414>3.0.CO;2-R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1855174%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference